Back

Welcome and introductions

19 May 2025 (12:30 - 12:33)
Organised by: Logo
Congress Presentation Part of: Does aldosterone synthase inhibition hold a key to transforming cardiorenal care? Aldosterone Antagonists HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

6 More presentations in this session

Presentation thumbnail
The integrated nature of cardiorenal metabolic health
Professor L. Lund (Stockholm, SE)
Slides
Presentation thumbnail
The role of aldosterone and its part in cardiorenal disease
Doctor M. Costanzo (Naperville, US)
Slides
Presentation thumbnail
Insights from the vicadrostat phase 2 study and implications for further clinical development
Doctor R. Mentz (Durham, US)
Slides
Presentation thumbnail
Aldosterone synthase inhibition and the future CRM treatment landscape
Professor J. Butler (Dallas, US)
Slides
Presentation thumbnail
Outlook, panel discussion and Q&A
Slides

Access the full session

Session thumbnail
Does aldosterone synthase inhibition hold a key to transforming cardiorenal care?
Video

The Event

Event poster

Heart Failure 2025

19 May 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Introduction and objectives
10 May 2023
thumbnail
Congress Session
ACNAP Doctoral Student Award
24 June 2023
thumbnail
Webinar
ESC Webinar : New 2018 Arterial Hypertension guidelines: which cut-off for which patient?
26 September 2018
thumbnail
Congress Session
The ESC Journal Family: focus on personalised care in different fields of cardiovascular medicine
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources